Sort
38,696 grants matching “als”
Collaborative Research: Dynamics of the Orkney Passage Outflow
$785,999Kurt L Polzin · Woods Hole Oceanographic Institution · · FY2015 · GEO
Immunoprotective Properties of Tissue-resident Memory T Cells in Mice and Humans within Mucosal Sites
$785,945Joshua Tisdell Schiffer · Fred Hutchinson Cancer Research Center · R01 · FY2020 · AI
Functional Organization of the Cerebral Cortex and Basal Ganglia
$785,549Charles R Gerfen · National Institute Of Mental Health · ZIA · FY2021 · MH
Pediatric toxicity and efficacy in long-term systemic treatment with anti-sense
$785,176John N Van Den Anker · Children'S Research Institute · U54 · FY2014 · HD
Molecular Targeted Photoimmunotherapy for Bladder Cancer
$785,005Piyush Agarwal · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
EVALUATION OF PPAR-DELTA/GAMMA AGONIST THERAPY AS A NOVEL TREATMENT PARADIGM FOR ALS
$784,854University Of California Irvine · · FY2020 · Defense Health Agency
Suicide Prevention with Substance Using Youth Experiencing Homelessness
$784,805Natasha Slesnick · Ohio State University · R01 · FY2025 · DA
Novel Formulations for Injectable Growth Factors
$784,795Bruce Lamb · Affinergy ,Inc · R44 · FY2009 · DE
Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce
$784,653Sheryl Zimmerman · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AG
Eritoran (E5564), a TLR4 antagonist, as a novel therapeutic for influenza
$784,554Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2013 · AI
Molecular Genetic Insight into Neurodegenerative Disease from Drosophila
$784,363Nancy M Bonini · University Of Pennsylvania · R35 · FY2023 · NS
Planned CORR: Planned Care for Obesity and Risk Reduction
$784,317Kevin Patrick · University Of California, San Diego · R01 · FY2008 · HL
LIGHT-ACTIVATED GENE EXPRESSION IN SINGLE CELLS(RMI)
$784,179Robert H Singer · Albert Einstein College Of Medicine · P20 · FY2007 · EB
Long-Term Nicotine Treatment of Mild Cognitive Impairment - Bridge Funding
$784,085Paul A. Newhouse · Vanderbilt University Medical Center · R01 · FY2020 · AG
Role of Th17 in Severe and Recurrent C. difficile Infection
$784,076William A Petri · University Of Virginia · R01 · FY2022 · AI
CHEMICAL GENETIC SCREENS FOR TDP-43 MODIFIERS AND ALS DRUG DISCOVERY
$784,074Universite De Montreal · · FY2011 · Department of Defense
Understanding and Mitigating Vascular Side-Effects Associated with Anti-Amyloid Immunotherapy
$783,917Cynthia A Lemere · Brigham And Women'S Hospital · R01 · FY2025 · NS
Molecular anatomy of human alveolar development
$783,750David Warburton · Children'S Hospital Of Los Angeles · U01 · FY2014 · HL
Transport Processes and Nervous System Function
$783,635Peter J. Basser · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2023 · HD
Regional Native American Community Networks Program
$783,596Dedra S Buchwald · University Of Washington · U01 · FY2006 · CA
Role of Th17 in Severe and Recurrent C. difficile Infection
$783,404William A Petri · University Of Virginia · R01 · FY2023 · AI
Kansas Community Cancer Health Disparities Network
$783,101K Allen Greiner · University Of Kansas Medical Center · U54 · FY2013 · CA
CRAFT for Parents of Adolescents in Outpatient Drug Treatment
$783,073Kimberly C Kirby · Treatment Research Institute · P50 · FY2012 · DA
Suicide Prevention with Substance Using Youth Experiencing Homelessness
$782,811Natasha Slesnick · Ohio State University · R01 · FY2023 · DA
TDP-43 acetylation, phase separation, aggregation, and clearance by antibody-mediated degradation
$782,427Don W. Cleveland · University Of California, San Diego · R01 · FY2022 · NS